Announcements Trials
Browse Landscape

Phase

Phase 1 28Phase 2 23Phase 1/2 11Phase 3 7Phase NA 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Metastasising Cancer of Unknown Primary 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Glioblastoma 1Esophageal Neoplasms 1Burkitt Lymphoma 1

Interventions

Temozolomide 2trametinib 1pembrolizumab 1dabrafenib 1Restraint, Physical 1Radiotherapy 1Radiosurgery 1Radiation 1Outcome Assessment, Health Care 1Observational Studies as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Glioblastoma × Radiation × Clear all
NCT00686725 2017-06-14

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Merck Sharp & Dohme LLC

Phase 4 Completed
99 enrolled 15 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡